Founded in 1912, the Fresenius Group is a healthcare company that provides products and services related to dialysis, hospital and patient home medical care. Fresenius Medical Care, a subsidiary of Fresenius Group, is the world's largest medical device company in the field of chronic kidney disease care, providing dialysis products and services to more than 300,000 patients worldwide, and the company is now the global market leader in dialysis.
According to the annual report for fiscal year 2021 net profit attributable to ordinary shareholders of the parent company amounted to 969 million euros, down 16.75 percent year-on-year, while operating income was 17,619 million euros, down 1.35 percent year-on-year.
In 2020, the company presented its 2025 strategy to keep its products and healthcare services at the core, and plans to focus on three key areas: the renal care continuum, critical care solutions and complementary assets.